Several recent studies have suggested that testicular germ cell tumors
express high levels of wild-type p53 protein, To clarify and confirm
this unexpected result, we have investigated seminomatous and nonsemin
ontatous germ cell tumors at the genomic, mRNA, and protein levels. Th
irty-five tumors were examined for p53 overexpression using antibodies
directed against the p53 (PAb1801, PAb240, and CMI), mdm2 (IF2), and
p21(Waf1/Cip1) (EA10) proteins, Thirty-two tumors were screened for p5
3 mutations by single-strand conformation polymorphism analysis. Eight
een tumors were screened with a functional assay that tests the transc
riptional competence of human p53 protein expressed in yeast On frozen
sections, 100, 65, 35, 73, and 0% of tumors reacted with the CMI, PAb
240, PAb1801, IF2, and EA10 antibodies, respectively, No p53 mutations
were detected by single-strand conformation polymorphism or by functi
onal assay. The fact that ma?ty tumors overexpress wild-type p53 hut n
ot mdm2 rules out mdma overexpression as a general explanation for the
presence of wildtype p53 in these tumors. The absence of p21 overexpr
ession suggests that p53 may be unable to activate transcription of cr
itical target genes, which may explain why the presence of wild-type p
53 is tolerated in this tumor type, although the mechanism for this tr
anscriptional inactivity remains to be established.